论文部分内容阅读
目的探究低分子肝素钙治疗不稳定型心绞痛的临床疗效。方法选取屯留县人民医院2013年4月—2014年4月收治的不稳定型心绞痛患者163例,将患者随机分为治疗组(76例)和对照组(87例)。对照组给予阿司匹林、硝酸之类、钙拮抗剂、β受体阻滞剂及调脂药治疗;心绞痛发作时舌下含化硝酸甘油。治疗组在基础治疗的基础上加用低分子肝素钙。比较两组患者的临床疗效。结果治疗组患者总有效率高于对照组,差异有统计学意义(χ2=6.64,P<0.05)。结论低分子肝素钙对治疗不稳定型心绞痛的临床效果显著,出血倾向较小,安全性好。
Objective To investigate the clinical efficacy of low molecular weight heparin in the treatment of unstable angina pectoris. Methods Totally 163 patients with unstable angina pectoris admitted from April 2013 to April 2014 in Tunliu County People’s Hospital were randomly divided into treatment group (76 cases) and control group (87 cases). Control group was given aspirin, nitric acid and the like, calcium antagonists, β-blockers and lipid-lowering drugs; angina pectoris sublingual nitroglycerin. Treatment group based on the basic treatment plus low molecular weight heparin. The clinical efficacy of the two groups was compared. Results The total effective rate of the treatment group was higher than that of the control group, the difference was statistically significant (χ2 = 6.64, P <0.05). Conclusion The low molecular weight heparin calcium is effective in treating unstable angina pectoris. The bleeding tendency is small and the safety is good.